AstraZeneca Vaccine Is Effective Against COVID-19, Phase III Study Says

Early results from an Oxford-AstraZeneca trial, which involved more than 32,000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.

Early results from an Oxford-AstraZeneca trial, which involved more than 32,000 volunteers, showed two doses of the vaccine administered four weeks apart had an efficacy of 79% at preventing symptoms of COVID-19.

Read More

Commentaires

Posts les plus consultés de ce blog

This Is What Fish Oil Supplements Actually Do

Chris Froome sends out strong message to his rivals as he storms back to win Criterium du Dauphine for the second time

Kid draws a hilarious family portrait, featuring his mother on her period